Ahlquist RP: A study of the adrenotropic receptors. Am J Physiol153:586-600, 1948
2.
Lands AM, Arnold A., McAuliff JP, et al: Differentiation of receptor systems activated by sympathomimeticamines . Nature214:597-598, 1967
3.
Bylund DB: Subtypes of alpha1- and alpha2-adrenergic receptors . FASEBJ6:832-839, 1992
4.
Starke K., Langer SZ: A note on terminology for presynaptic receptors, in Langer SZ, Starke K, Dubocovich ML (eds): Presynaptic Receptors. Oxford, UK, Pergamon Press, 1979, pp 1-3
5.
Langer SZ: Presynaptic regulation of catecholamine release. Biochem Pharmacol23:1793-1800,1974
Berthelsen S. , Pettinger WA: A functional basis for classification of alpha-adrenergic receptors. Life Sci21:595-606, 1977
8.
Ruffolo RR Jr, Nichols AJ, Stadel JM, Hieble JP: Pharmacologic and therapeutic applications of alpha2-adrenoceptor subtypes. Annu Rev Pharmacol Toxicol32:243-279, 1993
9.
Unnerstall JR , Kopajtic TA, Kuhar MJ: Distribution of alpha2-agonist binding sites in the rat and human central nervous system: Analysis of some functional, anatomic correlates of the pharmacologic effects of clonidine and related adrenergic agents. Brain Res319:69-101, 1984
10.
Vizi ES: Presynaptic modulation of neurochemical transmission. Prog Neurobiol12:181-290, 1979
11.
Drew GM, Whiting SB: Evidence for two distinct types of postsynaptic alpha-adrenoceptor in vascular smooth muscle in vivo. Br J Pharmacol67:207-215, 1979
12.
Berthelsen S. , Pettinger WA: A functional basis for classification of alpha-adrenergic receptors. Life Sci21:595-606, 1977
13.
Unnerstall JR, Kuhar MJ: Mapping the alpha-adrenergic receptor in the central nervous system: A guide to structure and function, in Stolk JM, U'Prichard DC, Fuxe K (eds): Epinephrine in the Central Nervous System. New York, NY, Oxford University Press, 1988, pp 45-59
14.
Bylund DB: Subtypes of alpha-2-adrenoceptors: Pharmacological and molecular biological evidence converge. TIPS9:356-361, 1988
15.
Maze M., Scheinin M.: Molecular pharmacology of alpha2adrenergic receptors. Anesth Pharm Rev1:233-237, 1993
16.
Maze M., Tranquilli W.: Alpha2-adrenoceptor agonists: Defining the role in clinical anesthesia . Anesthesiology74:581-605, 1991
17.
Coughlan MG , Lee JG, Bosnjak ZJ, et al: Direct coronary and cerebral vascular responses to dexmedetomidine: Significance of endogenous nitric oxide synthesis . Anesthesiology77:998-1006, 1992
18.
Aghajanian GK, VanderMaelen CP: Alpha2-adrenoceptor-mediated hyperpolarization of locus coeruleus neurons: Intracellular studies in vivo . Science215:1394-1396,1982
19.
Correa-Sales C., Rabin BC, Maze M.: A hypnotic response to dexmedetomidine, an alpha2-agonist, is mediated in the locus coeruleus in rats. Anesthesiology76:948-952, 1992
20.
Doze VA, Chen B-X., Maze M.: Dexmedetomidine produces a hypnotic-anesthetic action in rats via activation of central alpha2-adrenoceptors. Anesthesiology7175-7179, 1989
21.
Ruffolo RR, Turowski BS, Patil PN: Lack of crossdesensitization between structurally dissimilar alpha-adrenoceptor agonists. J Pharm Pharmacol29:378-380, 1977
22.
Ruffolo RR, Rice PJ, Patil PN, et al: Differences in the applicability of the Easson-Stedman hypothesis to the alpha1- and alpha2-adrenergic effects of phenethyl-amines and imidazolines. Eur J Pharmacol86:471-475, 1983
23.
Bousquet P. , Feldman J., Schwart J.: Central cardiovascular effects of alpha-adrenergic drugs: Differences between catecholamines and imidazolines. J Pharmacol Exp Ther230:232-236, 1984
24.
Ernsberger P., Meeley MP, Mann JJ, Reis DJ: Clonidine binds to imidazole binding sites as well as alpha2arenoceptors in the ventrolateral medulla. Eur J Pharmacol134:1-13, 1987
25.
Regunathan S., Reis DJ: Imidazoline receptors and their endogenous ligands. Annu Rev Pharmacol Toxicol36:511-544, 1996
26.
Reis DJ, Morrison S., Ruggiero DA: The C1 area of the brainstem in toic and reflex control of blood pressure: State of the art lecture. Hypertension11:18-13, 1988
27.
Bousquet P. , Feldman J., Tibirica E., et al: New concepts on the central regulation of blood pressure. Alpha2adrenoceptors and "imidazoline receptors."Am J Med87:10S-13S, 1989
28.
LehmannJ., Koenig-Berard E.Vitou P.: The imidazoline-preferring receptor. Life Sci45:1609-1615, 1989
29.
Guo TZ, Jiang JY, Butterman AE, Maze M.: Dexmedetomidine injection into locus ceruleus produces antinociception. Anesthesiology84:873-881, 1996
30.
Yamaguchi I. , Kopin IJ: Differential inhibition of alpha-1 and alpha-2 adrenoceptors-mediated pressor responses in pithed rates. J Pharmacol Exp Ther214:275-281, 1980
31.
Langer SZ, Shepperson NB: Recent developments in vascular smooth muscle pharmacology: The postsynaptic alpha2-adrenoceptor. Trends Pharmacol Sci3:440-444, 1982
32.
Langer SZ, Shepperson NB: Postjunctional alpha1adrenoceptors and the role of neuronal uptake . J Cardiovasc Pharmacol4:S8-13 (Suppl 1), 1982
33.
Nichols AJ, Hieble JP, Ruffolo RR: The pharmacology of peripheral alpha1- and alpha2-adrenoceptors . Rev Clin Basic Pharm7:129-205, 1988
34.
Cavero I., Shepperson N., Lefevre-Borg F., Langer SZ: Differential inhibition of vascular smooth muscle responses to alpha 1- and alpha2-adrenoceptor agonists by diltiazem and verapamil . Circ Res52:169-176, 1983
35.
van Meel JC , deJonge A., Kalkman HO, et al: Vascular smooth muscle contraction initiated by postsynaptic alpha2-adrenoceptor activation is induced by an influx of extracellular calcium. Eur J Pharmacol69:205-208, 1981
36.
van Meel JC , deJonge A., Kalkman HO, et al: Organic and inorganic calcium antagonists reduce vasoconstriction in vivo mediated by postsynatic alpha2-adrenoceptors . Naunyn Schmiedebergs Arch Pharmacol316:288-293, 1981
37.
Ruffolo RR: Stereochemical requirements for activation and blockade of alpha1- and alpha2-adrenoceptors. Trends Pharmacol Sci5:160-164, 1984
38.
Awad R., Payne R., Deth RC: Alpha adrenergic receptor subtype associated with receptor binding, Ca++ influx. Ca++ release and contractile events in the rabbit aorta. J Pharmacol Exp Ther227:60-67,1983
39.
Ruffolo RR Jr: Distribution and function of peripheral alpha-adrenoceptors in the cardiovascular system. Pharmacol Biochem Behav22:827-833, 1985
40.
MacLean MR, McCulloch KM, McGrath JC: Influences of the endothelium and hypoxia on alpha1 and alpha 2-adrenoceptor-mediated responses in the rabbit isolated pulmonary artery . Br J Pharmacol108:155-161, 1993
41.
Matsuda H., Kuon E., Holtz J., Busse R.: Endothelium-mediated dilations contribute to the polarity of the arterial wall in vasomotion induced by alpha2-adrenergic agonists. J Cardiovasc Pharmacol7:680-688, 1985
42.
Cocks TM, Angus JA: Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature305:627-630, 1983
43.
Egleme C., Godfraind T., Miller RC: Enhanced responsiveness of rat isolated aorta to clonidine after removal of the endothelial cells. Br J Pharmacol81:16-18, 1984
44.
Shimokawa H. , Flavahan NA, Vanhoutte PM: Natural course of the impairment of endothelium-dependent relaxations after balloon endothelium removal in porcine coronary arteries: Possible dysfunction of a pertussis toxin-sensitive G protein. Circ Res65:740-753, 1989
45.
Godfraind T., Egleme C., Al Osachie I.: Role of endothelium in the contractile response of rat aorta to aphaadrenoceptor agonists. Clin Sci68:65S-71S(Suppl 1), 1985
46.
Angus JA, Cocks TM, Satoh K.: The alpha adrenoceptors on endothelial cells. Fed Proc45:2355-2359, 1986
47.
Lues I., Schumann HJ: Effect of removing the endothelial cells on the reactivity of rat aortic segments to different alpha-adrenoceptor agonists. Naunyn Schmiedebergs Arch Pharmacol328:160-163, 1984
48.
Devcic A., Schmeling WT, Kampine JP, et al: Oral dexmedetomidine preserves baroreceptor function and decreases anesthetic requirements of halothane-anesthetized dogs. Anesthesiology81:419-430, 1994
49.
Haeusler G. : Activation of the central pathway of the baroreceptor reflex, a possible mechanism of the hypotensive action of clonidine. Naunyn Schmiedebergs Arch Pharmacol278:231-246, 1973
50.
Muzi M., Goff DR, Kampine JP, et al: Clonidine reduces sympathetic activity but maintains baroreflex responses in humans. Anesthesiology77:864-871, 1992
51.
Schmeling WT , Kampine JP, Roerig DL, Warltier DC: The effects of stereoisomers of the alpha 2-adrenergic agonist medetomidine on systemic and coronary hemodynamics in conscious dogs. Anesthesiology75:499-511, 1991
52.
Reis DJ, Granata AR, Joh TH, et al: Brain stem catecholamine mechanisms in toic and reflex control of blood pressure. Hypertension6:115-117, 1984
53.
Proctor LT, Schmeling WT, Roerig D., et al: Oral dexmedetomidine attenuates hemodynamic responses during emergence from general anesthesia in chronically instrumented dogs. Anesthesiology74:108-114, 1991
54.
Hausler G.: Further similarities between the action of clonidine and a central activation of the depressor baroreceptor reflex. Naunyn Schmiedebergs Arch Pharmacol285:1-14, 1974
55.
Schmitt H., Schmitt H.: Localization of the hypotensive effect of 2-(2,6-dichloraphenylamine)-2-imidazoline hydrochloride (ST-155, Catapresan). Eur J Pharmacol6:8-12,1969
56.
Laubie M., Schmitt H., Drouillat M.: Action of clonidine on the baroreceptor pathway and medullary sites mediating vagal bradycardia. Eur J Pharmacol38:293-303, 1976
57.
Drew GM: Effects of alpha-adrenoceptor agonists and antagonists on pre- and postsynaptically located alpha-adrenoceptor. Eur J Pharmacol36:313-320, 1976
58.
Lin W., Siedler FJ, McCook EC, Slotkin TA: Overexpression of alpha2-adrenergic receptors in fetal rat heart: Receptors in search of a function. J Dev Physiol17:183-187, 1992
59.
Eason MG, Liggett SB: Human alpha2-adrenergic receptor subtype distribution: Widespread and subtype selective expression of alpha2C10, alpha2C4, and alpha2C2 mRNA inmultiple tissues. Mol Pharmacol44:70-75, 1993
60.
Housmans R. : Effects of dexmedetomidine on contractility, relaxation and intracellular calcium transients of isolated ventricular myocardium . Anesthesiology73:919-922, 1990
61.
Flacke WE, Flacke JW, Blow KD, et al: Effect of dexmedetomidine, an alpha2-adrenergic agonist in the isolated heart. J Cardiovasc Anesth6:418-423, 1992
Karliner JS , Barnes P., Brown M., Dollery C.: Chronic heart failure in the guinea pig increases cardiac alpha1and beta-adrenoceptors. Eur J Pharmacol67:115-118, 1980
64.
Bloor BC, Frankland M., Alper G., et al: Hemodynamic and sedative effects of dexmedetomidine in dog. J Pharmacol Exp Ther263:690-697, 1992
65.
Lawrence CJ , Prinzen FW, de Lange S.: The effect of dexmedetomidine on the balance of myocardial energy requirement and oxygen supply and demand. Anesth Analg82:544-550, 1996
66.
Jones CJ, DeFily DV, PattersonJL, Chilian WM: Endothelium-dependent relaxation competes with alpha1- and alpha 2-adrenergic constriction in the canine epicardial coronary microcirculation . Circulation87:1264-1274, 1993
67.
Heusch G., Deussen A., Schipke J., Thamer V.: Alpha1and alpha2-adrenoceptor-mediated vascoconstriction of large and small canine coronary arteries in vivo. J Cardiovasc Pharmacol6:961-968, 1984
68.
Schulz R., Oudis RJ, Guth BD, Heusch G.: Minimal alpha1- and alpha2-adrenoceptor-mediated coronary vasconstriction in the anaesthetized swine. Naunyn Schmiedebergs Arch Pharmacol342:422-428, 1990
69.
Heusch G., Deussen A., Schipke J., et al: Role of cardiac sympathetic nerves in the genesis of myocardial ischemia distal to coronary stenosis. J Cardiovasc Pharmacol7:S13-18, 1985
Hotz J., Saeed M., Sommer O., Bassenge E.: Norepinephrine constricts the canine coronary bed via postsynaptic alpha 2-adrenoceptors. Eur J Pharmacol82:199-202, 1982
72.
Feigl EO: Adrenergic control of transmural coronary blood flow. Basic Res Cardiol85:167-76 (Suppl 1), 1990
73.
Hori M., Kitakze M., Tamai J., et al: Alpha2-adrenoceptor activity exerts dual control of coronary blood flow in canine coronary artery. Am J Physiol255:H250-H260, 1988
74.
Gross GJ, Winbury MM: Beta-adrenergic blockade on intramyocardial distribution of coronary blood flow. J Pharmacol187:451-464, 1973
75.
Seitelberger R., Guth BD, Heusch G., et al: Intracoronary alpha2-adrenergic receptor blockade attenuates ischemia in conscious dogs during exercise. Circ Res62:436-441, 1988
76.
Deussen A., Busch P., Schipke J., et al: Contribution of postsynatic alpha2-adrenoceptors to reflex sympathetic constriction of stenotic coronary vessles. Basic Res Cardiol85:193-206 (Suppl 1), 1990
77.
Strader JR, Gwirtz PA, Jones CE: Comparative effects of alpha1- and alpha2-adrenoceptors in mediation of coronary flow during exercise. J Pharmacol Exp Ther246:772-778, 1988
78.
Laxson DD, Dai XZ, Homans DC, Bache RJ: The role of alpha1-and alpha2-adrenergic receptors in mediation of coronary vasoconstriction in hypoperfused ischemic myocardium during exercise. Circ Res65:1688-1697, 1989
79.
Flacke WE, Flacke JW, Bloor BC, et al: Effects of dexmedetomidine on systemic and coronary hemodynamics in the anesthetized dog. J Cardiovasc Anesth7:41-49, 1993
80.
Savola JM, Brennan KM, Maze M., et al: No decrease in myocardial blood flow during infusion of dexmedetomidine as assessed using positron emission tomography in anaesthetized dogs. Eur J Pharmacol183:360-361, 1990
81.
Proctor LT, Schmeling WT, Warltier DC: Premedication with dexmedetomidine alters hemodynamic actions of intravenous anesthetic agents in chronically instrumented dogs. Anesthesiology77:554-562, 1992
82.
Kersten J., Pagel PS, Tessmer JP, et al: Dexmedetomidine alters the hemodynamic effects of desflurane and isoflurane in chronically instrumented dogs. Anesthesiology79:1022-1032, 1993
83.
KerstenJ., Pagel PS, Hettrick DA, Warltier DC: Dexmedetomidine partially attenuates the sympathetically mediated systemic and coronary hemodynamic effects of cocaine. Anesth Analg80:114-121, 1995
84.
Indolfi C., Piscioni F., Villari B., et al: Role of alpha2adrenoceptors in normal and atherosclerotic human coronary circulation. Circulation86:1116-1124, 1992
85.
Kono M., Morita S., Hayasni T., et al: The effects of intravenous colonidine on regional myocardial function in a canine model of regional myocardial ischemia. Anesth Analg78:1047-1052, 1994
86.
Schmeling WT , Farber NE: Anesthetic actions on cardiovascular control mechanisms in the central nervous system. Adv Pharmacol31:617-642, 1994
87.
Antonaccio MJ : Neuropharmacology of central mechanisms governing the circulation, in Antonaccio M (ed): Cardiovascular Pharmacology. New York, NY , Raven, 1977, pp 131-165
88.
Calaresu FR , Thomas MR: Electrophysiological connections in the brain stem involved in cardiovascular regulation. Brain Res87:335-338, 1975
89.
Calaresu FR , Ciriello J.: Electrophysiology of the hypothalamus in relation to central regulation of the cardiovdascular system, in Meyer P, Schmitt H, (eds): Brain andHypertension. 1979 , pp 129-136
90.
Schmeling WT , Hosko MJ, Hardman HF: Potentials evoked in the intermediolateral column by hypothalamic stimulation-supression by Delta9-tetrahydrocannabinol . Life Sci29:673-680, 1981
91.
Poterack KA , Kampine JP, Schmeling WT: Effects of isoflurane, midazolam, and etomidate on cardiovascular responses to stimulation of central nervous system pressor sites in chronically instrumented cats. Anesth Analg73:64-75, 1991
92.
Guyenet PG: Role of the ventral medulla oblongata in blood pressure regulation, in Loewy AD, Spyer KM (eds): Central Regulation of Autonomic Functions. New York, NY, Oxford University Press, 1990, pp 145-167
93.
Ross CA, Ruggiero DA, Park DH, et al: Tonic vasomotor control by the rostral ventrolateral medulla: Effect of electrical or chemical stimulation of the area containing C 1-adrenaline neurons on arterial pressure, heart rate, and plasma catecholamines and vasopressin. J Neurosci4:474-494, 1984
94.
Ciriello J. , Caverson MM, Polosa C.: Function of the ventrolateral medulla in the control of the circulation. Brain Res396:359-391, 1986
95.
Calaresu FR, Ciriello J., Caverson MM, et al: Functional neuroanatomy of central pathways controlling the circulation, in Guthrie GP Jr, Kotchen TA (eds): Hypertension and the Brain . Mount Kisco, NY, Futura Publishing Co, 1984, pp 3-21
96.
Ross CA, Ruggiero DA, Reis DJ: Afferent projections to cardiovascular portions of the nucleus of the tractrus solitarius in the rat. Brain Res223:402-408, 1981
97.
Spyer KM: Neural organisation and control of the baroreceptor reflex. Rev Physiol Biochem Pharmacol88:24-124, 1981
98.
Ross CA, Ruggiero DA, Reis DJ: Projections from the nucleus tractus solitarii to the rostral ventrolateral medulla. J Comp Neural242:511-534, 1985
99.
Isaac L.: Clonidine in the central nervous system: Site and mechanism of hypotensive action. J Cardiovasc Pharmacol2:S5-19 (Suppl 1 ), 1980
100.
Halson DW, Riddell JG, Shanks RG: Effects of azepexole and clonidine on baroreceptor-mediated reflex bradycardia and physiological tremor in man. Br J Clin Pharmacol20:431-436, 1985
101.
Spiers JP, Harron DW, Wilson R.: Acute and chronic effects of rilmenidine on baroreflex function in conscious dogs. Eur J Pharmacol181:235-240, 1990
102.
Farber NE, Samso E., Schwabe D., Schmeling WT: Dexmedetomidine modulates cardiovascular responses to stimulation of central nervous system pressor sites in cats anesthetized with halothane. Anesth Analg78(2S): S106, 1994
103.
Tranquilli WS, Maze M.: Clinical pharmacology and use of alpha 2-adrenergic agonists in veterinary anaesthesia. Anesth Pharm Rev1:297-309, 1993
104.
Jakola ML, Ali-Melkkila T., Kanto J., et al: Dexmedetomidine reduces intraoccular pressure, intubation responses and anesthetic requirements in patients undergoing ophthalmic surgery. Br J Anaesth68:570-575, 1992
105.
Ghignone M. , Quintin L., Duke PC, et al: Effects of clonidine on narcotic requirements and hemodynamic response during induction of fentanyl anesthesia and endeotracheal intubation. Anesthesiology64:36-42, 1986
106.
Flacke JW, Bloor BC, Flacke WE, et al: Reduced narcotic requirement by clondine with improved hemodynamic and adrenergic stability in patients undergoing coronary bypass surgery. Anesthesiology67:11-19, 1987
107.
Bloor BC, Flacke WE: Reduction in halothane anesthetic requirement by clonidine, an alpha-adrenergic agonist. Anesth Analg41:741-745, 1982
108.
Ghignone M. , Calvillo O., Quintin L.: Anesthesia and hypertension: The effect of clonidine on perioperative hemodynamics and isoflurane requirements. Anestheisology67:3, 1987
109.
Kenny D., Pelc LR, Brooks HL, et al: Alterations of alpha1- and alpha2-adrenoceptor—mediated pressor responses by halothane and isoflurane anesthesia. Anesthesiology71:224-234, 1989
110.
Foote SL, Bloom FE, Aston-Jones G.: Nucleus locus coeruleus: New evidence of anatomical and physiological specificity . Phys Rev63:844-914, 1983
111.
James IM, Larbi E., Zaimis E.: The effect of the acute intravenous administration of clonidine on cerebral blood flow in man. Br J Pharmacol39:198P-199P, 1970
112.
Greene CS, Cretier DD, Cervenka K., et al: Cerebral blood flow during the acute theraphy of severe hypertension with oral clonidine. Am J Emerg Med8:293-296, 1990
113.
Kanawati IS , Yaksh TL, Anderson RE, Marsh RW: Effects of clonidine on cerebral blood flow and the response to arterial CO2. J Cereb Blood Flow Metab6:358-365, 1986
114.
Karlsson BR , Forsman M., Roald OK, et al: Effect of dexmedetomidine, a selective and potent alpha2- agonist, or cerebral blood flow and oxygen consumption during halothane anesthesia in dogs. Anesth Analg71:125-129, 1990
115.
Zornow MH, Fleischer JE, Scheller MS, et al: Dexmedetomidine, and alpha2-adrenergic agonist, decreases cerebral blood flow in the isoflurane-anesthetized dog. Anesth Analg70:623-630, 1990
116.
McPherson RW, Kirsch JR, Traystman RJ: Inhibition of nitric oxide synthetase does not affect alpha2-adrenergic-mediated cerebral vasoconstriction. Anesth Analg78:67-72, 1994
117.
McPherson RW, Koehler RC, Traystman RJ: Hypoxia, alpha2-adrenergic, and nitric oxide-dependent interactions on canine cerebral blood flow. Am J Physiol226:H476-H482,1994
118.
Ishiyama T. , Dohi S., Iida H., et al: Mechanisms of dexmedetomidine-induced cerebrovascular effects in canine in vivo experiments. Anesth Analg81:1208-1215, 1995
119.
Smith JJ, Samso E., Hudetz B., et al: Dexmedetomidine: Effect on laser Doppler flow in the rat cerebral cortex. Anesthesiology81:695, 1994
120.
O'Brien WW , Coughlan M., Schmeling WT, et al: Differential effects of halothane and isoflurane on isolated cerebral artery segments contracted with dexmedetomidine . Anesthesiology81:696, 1994
121.
Maier C., Steinberg GK, Sun GH, et al: Neuroprotection by the alpha2-adrenoreceptor agonist dexmedetomidine in a focal model of crebral ischemia. Anesthesiology79:306-312, 1993
122.
Hoffman WE , Kochs E., Werner C., et al: Dexmedetomidine improves neurologic outcome from incomplete ischemia in the rate: Reversal by the alpha2 -adrenergic antagonist atipamezole. Anesthesiology75: 328-332,1991
123.
Kim HK, Zornow MH, Stranat Map: Dexmedetomidine does not attentuate increases in excitatory amino acids after transient global ischemia in the rabbit. Anesthesiology81:A8777, 1994
124.
Mangano DT , Hollenberg M., Fegert G., et al: SPI Research Group. Peri-operative myocardial ischemia in patients undergoing non-cardiac surgery. I: Incidence and severity during the 4 day peri-operative period. J Am Coll Cardiol7:843-850, 1991
Bonnet F., Liu R.: Delaunayl: Non-spinal use of alpha2adrenergic agonists for pain therapy. Anesth Pharm Rev1:284-287, 1993
127.
Ossipov MH , Gebhart GF: Absence of antinociceptive effect of alpha 2-agonists microinjected in periaqueductal gray of the rat. Brain Res289:349-354, 1983
128.
Spaulding TC, Venafro JJ, Ma MG, Fielding S.: The dissociation of the antinociceptive effect of clonidine from suprasprinal structures. NeuroPharmacol18:103-105,1979
129.
Aho M., Lehtinen AM, Erkola O., et al: The effect of intravenously administered dexmedetomidine on perioperative hemodynamics and isoflurane requirements in patients undergoing abdominal hysterectomy. Anesthesiology74:997-1002, 1991
130.
Aho M., Scheinin M., Lehtinen AM, et al: Intramuscularly administered dexmedetomidine attentuates hemodynamic and stress horomone responses to gynecologic laparoscopy. Anesth Analg75:932-939, 1992
131.
Aantaa R., Kanto J., Scheinin M., et al: Dexmedetomidine, an alpha2-adrenoreceptor agonist, reduces anesthetic requirements for patients undergoing minor gynecologic surgery. Anesthesiology73:230-235, 1990
132.
Bonnet F., Bioco O., Rostaing S., et al: Clonidine-induced analgesia in postoperative patients: Epidural versus intramuscular administration. Anesthesiology72:423-427, 1990
133.
Aho MS, Olli A., Scheinin H., et al: Effect of intravenously administered dexmedetomidine on pain after laparoscopic tubal ligation. Anesth Analg73:112-118, 1991
134.
Segal IS, Jarvis DJ, Duncan SR, et al: Clinical efficacy or oral-transdermal clonidine combination during the postoperative period. Anesthesiology74:220-225, 1991
135.
Kuraishi Y. , Hirota N., Sato Y., et al: Noradrenergic inhibition of the release of substance P from the primary afferents in the rabbit spinal dorsal horn . Brain Res259:177-182, 1985
Sabbe MB, Penning JP, Ozaki AS, Yaksh TL: Spinal and systemic action of the alpha2-receptor agonist dexmedetomidine in dogs. Anesthesiology80:1057-1072, 1994
138.
Murata K., Nakagawa I., Kumela Y., et al: Intrathecal clonidine suppres noxiously evoked activity of spinal wide dynamic range neurons in cats. Anesth Analg69:185-191,1989
139.
Jackson C. , Eisenach JC: Spinal administration of alpha2adrenergic agonists. Anesth Pharm Rev1:288-296, 1993
140.
Mendez R., Eisenach JC, Kastank: Epidural clonidine analgesia after cesarean section. Anesthesiology73:848-852, 1990
141.
Coombs DW, Jensen LB, Murphy C.: Microdose intrathecal clonidine and morphine for postoperative analgesia. Anesthesiology67:A238, 1987
142.
Samso E., Farber NF, Schwabe D., et al: Dexmedetomidine attenuates the somatosymapthetic reflex via spinal mechanisms. Anestheisology81:A938, 1994
143.
Weinger MB , Segal IS, Maze M.: Dexmedetomidine, acting through central alpha 2-adrenoceptors, prevents opiate-induced muscle rigidity in the rat . Anesthesiology71:242-249, 1989
144.
Schmeling WT, Kampine JP, Warltier DC: Dexmedetomidine attenuates the "shivering" upon the emergence from halothane anesthesia in chronically instrumented cats. Anesth Analg74:S264, 1992
145.
Glynn CJ: The spinal noradrenergic systems in the transmission of pain in patients, in Besson JM, Guilbaud G (eds): Towards the Use of Noradrenergic Agonists for the treatment of Pain. Excepta Medica Internaional Congress Series 1006. Amsterdam, Elsevier Science Publishers, 1992, pp 197-210
Glassman AH , Jackson WK, Walsh BT, et al: Cigarette craving, smoking withdrawal, and clonidine. Science226:864-866, 1984
149.
Tierney C. , Nadaud D., Koenig-Berard E., Stinus L.: Effects of two alpha2-agonists, rilmedidine and clonidine, on the morphine withdrawal systems and their potential addictive properties in rats. Am J Cardiol61:35D-38D, 1988
150.
Gossop M.: Clonidine and the treatment of the opiate withdrawal syndrome. Drug Alcohol Depend21:253-259, 1988
151.
Kamibayashi T., Hayashi Y., Mammoto T., et al: Role of the vagus nerve in the antidysrhythmic effect of dexmedetomidine on halothane/epinephrine dysrhythmias in dogs. Anesthesiology83:992-999, 1995
152.
Rotenberg FA, Verrier RL, Lown B., Sole MJ: Effects of clonidine on vulnerability to fibrillation in the normal and ishemic canine ventricle. Eur J Pharmacol47:71-79, 1978
153.
Chen SA, Lin RH, Ting TH, et al: Termination of digitalis-induced ventricular tachycardias by clonidine involves central alpha2-adrenoceptors in cats. BrJ Pharmacol103:1114-1118, 1991
154.
Kamibayashi T., Mammotot, Hayashi Y, et al: Further characterization of the receptor mechanism involved in the antidysrhythmic effect of dexmedetomidine on halothane/epinephrine dysrhythmias in dogs. Anesthesiology83:1082-1089, 1995
